EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers

BACKGROUND: The aim of the study was to investigate predictive value of gene mutation for atezolizumab treatment response from OAK and POPLAR cohorts. METHODS: Several public databases were used for analyzing gene mutation type of EPHA5 and association with alterations of other genes. Survival analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenxiang, Zhou, Qing, Wang, Qi, Wang, Haiyong, Yue, Weiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487080/
https://www.ncbi.nlm.nih.gov/pubmed/36123678
http://dx.doi.org/10.1186/s12890-022-02161-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487080/
https://www.ncbi.nlm.nih.gov/pubmed/36123678
http://dx.doi.org/10.1186/s12890-022-02161-1

Ejemplares similares